{"nct_id":"NCT06435845","title":"Phase 2 Study on the Pharmacokinetics and Safety of RLYB212 in Pregnant Women at Higher Risk for HPA-1a Alloimmunization","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-06","start_date":"2024-11-21","start_date_type":"ACTUAL","primary_completion_date":"2027-05","primary_completion_date_type":"ESTIMATED","completion_date":"2027-05","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["RLYB"]}